Pinter; Abraham

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pinter; Abraham.The latest application filed is for "novel anti-lam and anti-pim6/lam monoclonal antibodies for diagnosis and treatment of mycobacterium tuberculosis infections".

Company Profile

3.14.13

Pinter; Abraham - Brooklyn NY
Pinter; Abraham - New York NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Novel Anti-lam And Anti-pim6/lam Monoclonal Antibodies For Diagnosis And Treatment Of Mycobacterium Tuberculosis Infections App 20220168420 - Pinter; Abraham ; et al.	2022-06-02
Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of Mycobacterium tuberculosis infections Grant 11,273,220 - Pinter , et al. March 15, 2	2022-03-15
Methods For Dual Detection And Differentiation Of Infection By Mycobacterium Tuberculosis Complex And Nontuberculous Mycobacteria App 20210302424 - Pinter; Abraham	2021-09-30
Novel Anti-lam And Anti-pim6/lam Monoclonal Antibodies For Diagnosis And Treatment Of Mycobacterium Tuberculosis Infections App 20200316199 - Pinter; Abraham ; et al.	2020-10-08
Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of Mycobacterium tuberculosis infections Grant 10,729,771 - Pinter , et al.	2020-08-04
Novel Anti-lam And Anti-pim6/lam Monoclonal Antibodies For Diagnosis And Treatment Of Mycobacterium Tuberculosis Infections App 20190038747 - Pinter; Abraham ; et al.	2019-02-07
HIV-1 antigens with discrete conformational forms in the V1/V2 domain and methods of use thereof Grant 9,938,325 - Pinter April 10, 2	2018-04-10
Neutralizing antibodies that bind to the HIV-1 Env V2 critical neutralization domain Grant 9,796,773 - Pinter October 24, 2	2017-10-24
Hiv-1 Antigens With Discrete Conformational Forms On The V1/v2 Domain And Methods Of Use Thereof App 20160257720 - Pinter; Abraham	2016-09-08
Hiv-1 Peptides, Nucleic Acids, And Compositions, And Uses Thereof App 20150175679 - Pinter; Abraham	2015-06-25
Immunogen comprising the HIV GP120 V3 loop in a conformation that induces broadly neutralizing antibodies Grant 8,961,987 - Zolla-Pazner , et al. February 24, 2	2015-02-24
Immunogenic Polypeptides Having An Immunogenic Scaffold Protein And A Loop Peptide, Presenting A 3074- Or 2219/2557- Monoclonal Antibody-targeted Epitope, Which Is Present In The Hiv Gp120 Protein App 20130287804 - Cardozo; Timothy ; et al.	2013-10-31
HIV-1 GP41 neutralization domain and use thereof Grant 8,475,799 - Pinter July 2, 2	2013-07-02
HIV-1 Peptides, Nucleic Acids, and Compositions and Uses Thereof App 20110311569 - Pinter; Abraham	2011-12-22
Hiv-1 Gp41 Neutralization Domain And Use Thereof App 20110091491 - Pinter; Abraham	2011-04-21
Immunogen Presenting Hiv Gp120 V3 Loop In A Conformation That Induces Broadly Neutralizing Antibodies App 20090098144 - ZOLLA-PAZNER; Susan ; et al.	2009-04-16
Use of transgenic mice for the efficient isolation of novel human monoclonal antibodies with neutralizing activity against primary HIV-1 strains and novel HIV-1 neutralizing antibodies App 20050058983 - Pinter, Abraham ; et al.	2005-03-17
HIV-1 gp120 V1/V2 domain epitopes capable of generating neutralizing antibodies Grant 6,815,201 - Pinter November 9, 2	2004-11-09
HIV-1 gp120 V1/V2 domain epitopes capable of generating neutralizing antibodies App 20030105282 - Pinter, Abraham	2003-06-05
Fusion glycoproteins Grant 5,952,474 - Kayman , et al. September 14, 1	1999-09-14
Synergistic neutralization of HIV-1 by human monoclonal antibodies and other antibodies directed against the v3 loop and the CD-4 binding site of GP-120,and the use for immunotherapy of HIV-1 infection Grant 5,922,325 - Tilley , et al. July 13, 1	1999-07-13
Fusion glycoproteins Grant 5,643,756 - Kayman , et al. July 1, 1	1997-07-01
Selection of ribozymes that efficiently cleave target RNA Grant 5,616,459 - Kramer , et al. April 1, 1	1997-04-01
Preparation of native oncornavirus envelope subunits and vaccines therefrom Grant 4,406,885 - Pinter September 27, 1	1983-09-27

Company Registrations

NCAGE Code	49FJ1	PINTER ABRAHAM!DBA ABCS
CAGE Code	49FJ1	PINTER, ABRAHAM ABCS
DUNS	613453062	PINTER, ABRAHAM

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.